Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astrazeneca Plc (AZN)
NASDAQ:AZN
Holding AZN?
Track your performance easily
AZN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$60.47 - $87.68
Previous Close$78.53
Volume2.61M
Average Volume (3M)4.45M
Market Cap
$244.32B
Enterprise Value$267.13B
Total Cash (Recent Filing)$5.84B
Total Debt (Recent Filing)$28.62B
Price to Earnings (P/E)38.0
Beta0.46
Next Earnings
Nov 12, 2024EPS Estimate
$1.05Last Dividend Ex-Date
Aug 09, 2024Dividend Yield1.84%
Share Statistics
EPS (TTM)2.08
Shares Outstanding3,100,573,274
10 Day Avg. Volume5,570,162
30 Day Avg. Volume4,447,549
Standard Deviation0.06
R-Squared0.17
Alpha0.00902
Financial Highlights & Ratios
Price to Book (P/B)3.08
Price to Sales (P/S)4.98
Price to Cash Flow (P/CF)22.00
P/FCF Ratio30.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.02
Enterprise Value/Gross Profit7.12
Enterprise Value/Ebitda29.41
Forecast
1Y Price Target
$88.83Price Target Upside13.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
AstraZeneca News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reported total revenues of $12.938bn, beating consensus of $12.571bn by 3%.
Guidance And GrowthIncreased FY24 guidance reflective of management expectations of core product growth.
Product And PipelineKey products mostly outperformed consensus, driven by Symbicort (+28%), Farxiga (+5%) and Ultomiris (+4%).
Bears Say
Clinical TrialsThe Phase 3 trial CAPItello-290 evaluating capivasertib (capi, Truqap) + paclitaxel in 1L triple negative breast cancer (TNBC) did not meet its dual primary endpoint of OS vs placebo + paclitaxel.
Profit MarginThe operating profit margin was 32%, reigniting investor concerns about high expenses.
Revenue GuidanceThe guidance change for Collaboration revenues was a negative surprise, but it also highlights management's view on its core business.
---
Ownership Overview
0.00%
Insiders
7.01% Mutual Funds
7.08% Other Institutional Investors
85.91% Public Companies and Individual Investors
AZN FAQ
What was Astrazeneca Plc’s price range in the past 12 months?
Astrazeneca Plc lowest stock price was $60.47 and its highest was $87.67 in the past 12 months.
What is Astrazeneca Plc’s market cap?
Currently, no data Available
When is Astrazeneca Plc’s upcoming earnings report date?
Astrazeneca Plc’s upcoming earnings report date is Nov 12, 2024 which is in 54 days.
How were Astrazeneca Plc’s earnings last quarter?
Astrazeneca Plc released its earnings results on Jul 25, 2024. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.983 by $0.007.
Is Astrazeneca Plc overvalued?
According to Wall Street analysts Astrazeneca Plc’s price is currently Undervalued.
Does Astrazeneca Plc pay dividends?
Astrazeneca Plc pays a Semiannually dividend of $0.49 which represents an annual dividend yield of 1.84%. See more information on Astrazeneca Plc dividends here
What is Astrazeneca Plc’s EPS estimate?
Astrazeneca Plc’s EPS estimate is $1.05.
How many shares outstanding does Astrazeneca Plc have?
Astrazeneca Plc has 3,100,573,200 shares outstanding.
What happened to Astrazeneca Plc’s price movement after its last earnings report?
Astrazeneca Plc reported an EPS of $0.99 in its last earnings report, beating expectations of $0.983. Following the earnings report the stock price went down -1.489%.
Which hedge fund is a major shareholder of Astrazeneca Plc?
Among the largest hedge funds holding Astrazeneca Plc’s share is PRIMECAP Management Co. It holds Astrazeneca Plc’s shares valued at 3B.
---
AstraZeneca Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$88.83 (13.04% Upside)
$88.83 (13.04% Upside)
Blogger Sentiment
Bullish
AZN Sentiment 96%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 5.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.46%
12-Months-Change
Fundamentals
Return on Equity
16.75%
Trailing 12-Months
Asset Growth
8.08%
Trailing 12-Months
Company Description
Astrazeneca Plc
Founded in 1992, UK-based AstraZeneca Plc is a leading global pharmaceutical company, which is engaged in delivering life-changing medicines. The company produces and commercializes medicines for cancer, gastrointestinal, cardiovascular, neuroscience, oncology, respiratory and inflammation and other infectious diseases.
---
AZN Company Deck
---
AZN Earnings Call
Q2 2024
0:00 / 0:00
---
AZN Stock 12 Month Forecast
Average Price Target
$88.83
▲(13.04% Upside)
Technical Analysis
Best Analysts Covering AZN
1 Year
1 Year Success Rate
31/35 ratings generated profit
1 Year Average Return
+12.37%
reiterated a buy rating 2 months ago
Copying Andrew Berens's trades and holding each position for 1 Year would result in 88.57% of your transactions generating a profit, with an average return of +12.37% per trade.
---